Effects of Emicizumab Treatment in Patients With Hemophilia A
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age1-18
SponsorHasan Kalyoncu University
About this trial
The aim of our study is to investigate the effects of emicizumab treatment on the musculoskeletal system in children with hemophilia A.
Eligibility criteria
Qualifiers
Children who are under 18 years of age,
Have been diagnosed with Hemophilia A by a physician,
Have a factor level of 1% (IU) or less,
Have inhibitors positive or negative,
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
20 Participants
are grouped into 1 trial groupLocations
1Hasan Kalyoncu University(505) 090-5846, GaziantepGaziantep, Turkey (Türkiye)
Sponsors and collaborators
Hasan Kalyoncu University
Lead sponsor
Source ClinicalTrials.gov